UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International TravellersUK

UK has added India's indigenously-made Covaxin to its list of approved Coronavirus vaccines for international travellers.

The move will benefit more fully vaccinated Indians planning travel to the UK without the need for a pre-departure PCR test or self-isolation at the address declared on their compulsory Passenger Locator Forms, reports NewsOnAIR.

Covaxin, which is developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is the seventh Covid-19 jab that has been approved for International travellers in the UK. Earlier, the UK government had approved vaccines from Oxford/AstraZeneca, Pfizer-BioNTech, Moderna, J&J, Sinovac and Sinopharm for the international travellers.

Earlier the, the Bharat Biotech manufactured Covaxin had received its WHO emergency use listing status, resulting in the UK announcing plans to include it on its list of approved COVID vaccines from 22 November.

The WHO Emergency Use Listing process includes a review of the quality, safety and efficacy data performed by WHO experts, and many countries such as the United States, Spain, Sweden, Switzerland and Iceland recognise this categorisation.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement